In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2.
about
PlncRNA-1 induces apoptosis through the Her-2 pathway in prostate cancer cells.Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC).Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC.Lapatinib-induced mesenchymal-epithelial transition in squamous cell carcinoma cells correlates with unexpected alteration of β-catenin expression.Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells.
P2860
In vitro antiproliferative effect of trastuzumab (Herceptin(®)) combined with cetuximab (Erbitux(®)) in a model of human non-small cell lung cancer expressing EGFR and HER2.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
In vitro antiproliferative eff ...... ncer expressing EGFR and HER2.
@en
type
label
In vitro antiproliferative eff ...... ncer expressing EGFR and HER2.
@en
prefLabel
In vitro antiproliferative eff ...... ncer expressing EGFR and HER2.
@en
P2093
P2860
P50
P1476
In vitro antiproliferative eff ...... ancer expressing EGFR and HER2
@en
P2093
P2860
P2888
P304
P356
10.1007/S10238-015-0343-8
P577
2015-02-26T00:00:00Z
P5875
P6179
1020809487